Patient Pathfinder: Clinical Trials
Clinical Trials for Bladder Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 258 active Bladder Cancer trials
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Study Type: Interventional Phase 3
A Study of LOXO-435 in Patients With Cancer With a Change in a Gene Called FGFR3
Study Type: Interventional Phase 1
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
Study Type: Interventional Phase 2
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
Study Type: Observational
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers
Study Type: Interventional Phase 2
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer
Study Type: Interventional Phase 3
Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Study Type: Interventional Phase 2
Gender Related Coping and Survivorship for Genitourinary Cancers
Study Type: Observational
There are 258 active Bladder Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now